Cargando…
Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein
Eltrombopag is a small molecule TPO-R agonist that has been shown in our previous studies to inhibit tumor growth by targeting Human antigen R (HuR) protein. HuR protein not only regulates the mRNA stability of tumor growth-related genes, but it also regulates the mRNA stability of a variety of canc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963984/ https://www.ncbi.nlm.nih.gov/pubmed/36834574 http://dx.doi.org/10.3390/ijms24043164 |